Cara Therapeutics Announces Presentations at Kidney Week 2019
Late-breaking oral presentation to highlight data from KALM-1 pivotal Phase 3 trial of KORSUVA™ Injection in hemodialysis patients with pruritus.
Read MoreCategory: Biomedical
Novus Therapeutics Receives FDA Guidance on OP0201 Phase 2a Study in Patients with Chronic Otitis Media with Effusion
Study C-009 is designed to explore the effect of daily administration of OP0201 in patients with COME, a non-infectious form of otitis media.
Read More
KALY – Kali-Extracts To Review Acquisition Interest In Its Cannabis Extract Biopharmaceutical Technology This Wednesday, October 30, 2019
Investors are recognizing that KALY’s technology is undervalued.
Read More
Media Alert: Liquid Gold Distillate: The New Cannabis Currency
Liquid Gold Distillate: The New Cannabis Currency – is an amber-coloured purified distillate that can be worth more than the value of gold.
Read More
Cara Therapeutics Announces Completion of Interim Statistical Assessment and Small Increase in Target Enrollment for KALM-2 Phase 3 Global Trial of KORSUVA™ Injection in Hemodialysis Patients with Pruritus
Patient enrollment increased approximately 20% to maintain >90% statistical power.
Read MoreGET LISTED
